Docusign stock dropped 12% due to disappointing billings figures and reduced full-year guidance

Docusign’s first-quarter earnings report showed growth in revenue and adjusted net income, beating analyst estimates. However, the stock dropped over 12% in June due to disappointing billings figures and reduced full-year guidance. The company also announced a $1 billion increase in its share repurchase program, with $1.4 billion remaining for buybacks.

The disappointing billings performance was attributed to slow adoption of Docusign’s new Intelligent Agreement Management platform. While this impacted results, the platform offers advanced functionality for customers. Despite concerns about billings, Docusign’s solid business model and future potential remain positive for investors. The company’s stock was not included in the Motley Fool’s top 10 stock picks for investors.

Investors should monitor Docusign’s billings performance going forward, as it plays a crucial role in the company’s financial outlook. The Motley Fool Stock Advisor team has a history of identifying stocks with significant returns, providing valuable insights for investors. Docusign’s recent stock performance highlights the importance of staying informed and making strategic investment decisions based on thorough research.

Read more at Yahoo Finance: Why Docusign Stock Stumbled Last Month